Both GLP-1 and its agonists (GLP-1RAs) have been identified for suppressing appetite, slowing gastric emptying time, and inducing fullness and satiety, thereby reducing caloric intake under ad libitum feeding conditions (139141)
A: From what you describe, this sounds like a titration (changing medication dose) issue
This approach lets you establish a baseline for bupropion side effects, confirm the antidepressant dose is correct, and ensure you tolerate the medication before adding the complexity of tirzepatide
Some data suggests stability extends to 28 days at controlled room temperature for specific brand-name formulations, but remember, those formulations contain stabilizers that compounded versions typically lack
This treatment mimics the GLP-1 hormone, targeting brain regions that control appetite and food intake, effectively reducing hunger and enhancing feelings of fullness